Maravai Lifesciences Holdings (MRVI) Inventory Average (2021 - 2026)

Maravai Lifesciences Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $40.5 million for Q1 2026.

• In Q1 2026, Inventory Average fell 18.93% year-over-year to $40.5 million; the TTM figure through Mar 2026 stood at $40.5 million (down 18.93% YoY), while the FY2025 annual figure was $45.3 million, down 10.74% from the prior year.
• Inventory Average for Q1 2026 stood at $40.5 million, down from $42.9 million in the prior quarter.
• The five-year high for Inventory Average was $61.3 million in Q3 2022, with the low at $40.5 million in Q1 2026.
• The 5-year median for Inventory Average is $49.9 million (2024), against an average of $49.9 million.
• The sharpest annual moves came in 2022 and 2023: Inventory Average rose 28.02% in 2022, then dropped 21.21% in 2023.
• Maravai Lifesciences Holdings' Inventory Average stood at $52.8 million in 2022, then retreated by 4.77% to $50.3 million in 2023, then increased by 0.08% to $50.3 million in 2024, then slipped by 14.7% to $42.9 million in 2025, then slipped by 5.67% to $40.5 million in 2026.
• Business Quant data shows MRVI's Inventory Average at $40.5 million in Q1 2026, $42.9 million in Q4 2025, and $46.0 million in Q3 2025.